Stroke Trial, Recruiting NCT07591272 Sponsor: Chinese University of Hong Kong Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07591272
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had a first or repeat stroke (either a blocked blood vessel or a bleed in the brain), confirmed by a brain scan
  • People who are currently staying in hospital at an acute stroke unit
  • People whose stroke has been assessed as mild to moderate in severity, based on a standard medical scoring tool called the NIHSS (with a total score below 16)
  • People who have weakness on one side of the body after stroke, where the affected arm and/or leg has some movement but is significantly weakened (scoring 1–3 on the NIHSS motor items)
  • People with a moderate level of disability after stroke, as measured by a standard scale called the modified Rankin Scale (scoring between 2 and 4)
  • People whose thinking and memory abilities are above the 2nd percentile on a standard cognitive assessment called the MoCA

Who may not be able to join:

  • People whose stroke symptoms were temporary and fully resolved (known as a transient ischaemic attack or TIA)
  • People whose brain bleed occurred between the brain and the skull (subdural or epidural haemorrhage)
  • People whose stroke was caused by a brain tumour or a head injury
  • People with a pre-existing neurological, bone and joint, muscle, rheumatic, or inner-ear/balance condition that could affect participation — such as epilepsy or a spinal injury
  • People with a mental health condition such as depression or schizophrenia
  • People with vision or hearing problems that cannot be adequately corrected with glasses or hearing aids

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 852-39434485

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
31 December 2028

Where this trial is recruiting

Hong Kong

Primary endpoints

Change in the level of participation in daily and social activities

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov